Invention Grant
- Patent Title: Inhibition of JAK2 as a treatment of pulmonary arterial hypertension
- Patent Title (中): 抑制JAK2作为肺动脉高压的治疗
-
Application No.: US12280327Application Date: 2007-02-28
-
Publication No.: US08410173B2Publication Date: 2013-04-02
- Inventor: Lawrence S. Zisman
- Applicant: Lawrence S. Zisman
- Applicant Address: AU Melbourne, Victoria
- Assignee: YM Biosciences Australia Pty Ltd
- Current Assignee: YM Biosciences Australia Pty Ltd
- Current Assignee Address: AU Melbourne, Victoria
- Agency: Morrison & Foerster LLP
- International Application: PCT/US2007/062932 WO 20070228
- International Announcement: WO2007/101232 WO 20070907
- Main IPC: A61K31/165
- IPC: A61K31/165
Abstract:
The present invention relates to a method of treating pulmonary arterial hypertension by administering a therapeutically effective amount of a selective JAK2 inhibitor to a patient in need thereof.
Public/Granted literature
- US20110117159A1 INHIBITION OF JAK2 AS A TREATMENT OF PULMONARY ARTERIAL HYPERTENSION Public/Granted day:2011-05-19
Information query
